Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?
Buying shares of early stage biotech companies is one of the ways that cash-strapped investors can plant the seeds of massive growth. Citius Pharmaceuticals (NASDAQ: CTXR) is typical of such a small biotech: It doesn't have any revenue or profits, and its only hope of getting either is to follow through on its drugs in development. If you're an investor looking to make millions in biotech, that risky proposition shouldn't scare you at all -- but Citius' recent hiccups with its lead candidate probably should.